Alpha1beta1 and integrin-linked kinase interact and modulate angiotensin II effects in vascular smooth muscle cells

Atherosclerosis

Volumn 243, Issue 2, 2015, Pages 477-485

  Moraes, João Alfredo ^a   Frony, Ana Clara ^a   Dias, Aline Maria ^a   Renovato Martins, Mariana ^a   Rodrigues, Genilson ^a   Marcinkiewicz, Cezary ^b   Assreuy, Jamil ^c   Barja Fidalgo, Christina ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Temple University   (United States)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Alpha1beta1 integrin; Angiotensin II; ILK; NOX; Obtustatin; Vascular smooth muscle cell

Indexed keywords

ANGIOTENSIN II; APOCYNIN; INTEGRIN LINKED KINASE; OBTUSTATIN; PROTEIN INHIBITOR; PROTEIN KINASE B; PROTEIN P21; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 1; ACETOPHENONE DERIVATIVE; CDKN1A PROTEIN, RAT; CYBB PROTEIN, RAT; CYCLIN DEPENDENT KINASE INHIBITOR 1A; ENZYME INHIBITOR; FOCAL ADHESION KINASE 1; INTEGRIN-LINKED KINASE; MEMBRANE PROTEIN; OBTUSTATIN, VIPERA LEBETINA OBTUSA; OXIDOREDUCTASE; PROTEIN SERINE THREONINE KINASE; PTK2 PROTEIN, RAT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VIPER VENOM;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FOCAL ADHESION; GENE SILENCING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL MOTION; DRUG EFFECTS; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHOSPHORYLATION; RNA INTERFERENCE; SMOOTH MUSCLE CELL; THORACIC AORTA; TIME FACTOR; VASCULAR SMOOTH MUSCLE; WISTAR RAT;

ACETOPHENONES; ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ENZYME INHIBITORS; FOCAL ADHESION KINASE 1; INTEGRIN ALPHA1BETA1; MALE; MEMBRANE GLYCOPROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-AKT; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; VIPER VENOMS;

EID: 84946098638     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.09.026     Document Type: Article

References (39)

1. Back M., Bu D.X., Branstrom R., et al. Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:17501-17506.
2. Willis A.I., Pierre-Paul D., Sumpio B.E., et al. Vascular smooth muscle cell migration: current research and clinical implications. Vasc. Endovascular Surg. 2004, 38:11-23.
3. Curcio A., Torella D., Indolfi C. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ. J. Off. J. Jpn. Circ. Soc. 2011, 75:1287-1296.
4. Marx S.O., Totary-Jain H., Marks A.R. Vascular smooth muscle cell proliferation in restenosis. Circ. Cardiovasc. Interv. 2011, 4:104-111.
5. Johnson J.L. Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis. Cardiovasc. Res. 2014, 103:452-460.
6. Libby P. Inflammation in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2045-2051.
7. Montezano A.C., Nguyen Dinh Cat A., Rios F.J., et al. Angiotensin II and vascular injury. Curr. Hypertens. Rep. 2014, 16:431.
8. Bunni M.A., Kramarenko, Walker L., et al. Role of integrins in angiotensin II-induced proliferation of vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2011, 300:C647-C656.
9. Valente A.J., Yoshida T., Murthy S.N., et al. Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18. Am. J. Physiol. Heart Circ. Physiol. 2012, 303:H282-H296.
10. Shen Y.J., Zhu X.X., Yang X., et al. Cardamonin inhibits angiotensin II-induced vascular smooth muscle cell proliferation and migration by downregulating p38 MAPK, Akt, and ERK phosphorylation. J. Nat. Med. 2014, 68:623-629.
11. Cave A. Selective targeting of NADPH oxidase for cardiovascular protection. Curr. Opin. Pharmacol. 2009, 9:208-213.
12. Griendling K.K., Sorescu D., Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 2000, 86:494-501.
13. Schroder K. Isoform specific functions of Nox protein-derived reactive oxygen species in the vasculature. Curr. Opin. Pharmacol. 2010, 10:122-126.
14. Nguyen Dinh Cat A., Montezano A.C., Burger D., et al. Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. Antioxid. Redox Signal. 2013, 19:1110-1120.
15. Sareila O., Kelkka T., Pizzolla A., et al. NOX2 complex-derived ROS as immune regulators. Antioxid. Redox Signal. 2011, 15:2197-2208.
16. Li J.J., Han M., Wen J.K., et al. Osteopontin stimulates vascular smooth muscle cell migration by inducing FAK phosphorylation and ILK dephosphorylation. Biochem. Biophys. Res. Commun. 2007, 356:13-19.
17. Varadarajulu J., Laser M., Hupp M., et al. Targeting of alpha(v) integrins interferes with FAK activation and smooth muscle cell migration and invasion. Biochem. Biophys. Res. Commun. 2005, 331:404-412.
18. Moraes J., Assreuy J., Canetti C., et al. Leukotriene B4 mediates vascular smooth muscle cell migration through alphavbeta3 integrin transactivation. Atherosclerosis 2010, 212:406-413.
19. Choi E.T., Khan M.F., Leidenfrost J.E., et al. Beta3-integrin mediates smooth muscle cell accumulation in neointima after carotid ligation in mice. Circulation 2004, 109:1564-1569.
20. Katsuda S., Okada Y., Minamoto T., et al. Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies. Arterioscler. Thromb. J. Vasc. Biol. Am. Heart Assoc. 1992, 12:494-502.
21. Louis H., Kakou A., Regnault V., et al. Role of alpha1beta1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H2597-H2604.
22. Nguyen T.T., Ward J.P., Hirst S.J. beta1-Integrins mediate enhancement of airway smooth muscle proliferation by collagen and fibronectin. Am. J. Respir. Crit. Care Med. 2005, 171:217-223.
23. Schapira K., Lutgens E., de Fougerolles A., et al. Genetic deletion or antibody blockade of alpha1beta1 integrin induces a stable plaque phenotype in ApoE-/- mice. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1917-1924.
24. Qin J., Wu C. ILK: a pseudokinase in the center stage of cell-matrix adhesion and signaling. Curr. Opin. Cell Biol. 2012, 24:607-613.
25. Imai Y., Clemmons D.R. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I. Endocrinology 1999, 140:4228-4235.
26. Yang Z.Y., Simari R.D., Perkins N.D., et al. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:7905-7910.
27. Bettink S.I., Werner C., Chen C.H., et al. Integrin-linked kinase is a central mediator in angiotensin II type 1- and chemokine receptor CXCR4 signaling in myocardial hypertrophy. Biochem. Biophys. Res. Commun. 2010, 397:208-213.
28. Marcinkiewicz C., Weinreb P.H., Calvete J.J., et al. Obtustatin: a potent selective inhibitor of alpha1beta1 integrin in vitro and angiogenesis in vivo. Cancer Res. 2003, 63:2020-2023.
29. Moreno-Murciano M.P., Monleon D., Calvete J.J., et al. Amino acid sequence and homology modeling of obtustatin, a novel non-RGD-containing short disintegrin isolated from the venom of Vipera lebetina obtusa. Protein Sci. Publ. Protein Soc. 2003, 12:366-371.
30. Moraes J.A., Frony A.C., Dias A.M., et al. Data in support of alpha1beta1 and integrin-linked kinase interact and modulate angiotensin II effects in vascular smooth muscle cells. Data Brief 2015, (in press).
31. Marshall C., Mamary A.J., Verhoeven A.J., et al. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am. J. Respir. Cell Mol. Biol. 1996, 15(5):633-644.
32. Qin H.D., Huang D., Weng X.D., et al. Upregulation of peroxisome proliferator-activated receptor-gamma and NADPH oxidases are involved in restenosis after balloon injury. J. Cell. Physiol. 2009, 221(2):387-393.
33. Arold S.T. How focal adhesion kinase achieves regulation by linking ligand binding, localization and action. Curr. Opin. Struct. Biol. 2011, 21:808-813.
34. Han S.Y., Kang Y.S., Jee Y.H., et al. High glucose and angiotensin II increase beta1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes. Cell Tissue Res. 2006, 323:321-332.
35. Persad S., Attwell S., Gray V., et al. Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J. Biol. Chem. 2001, 276:27462-27469.
36. Lacolley P., Regnault V., Nicoletti A., et al. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc. Res. 2012, 95:194-204.
37. Massey K.J., Hong N.J., Garvin J.L. Angiotensin II stimulates superoxide production in the thick ascending limb by activating NOX4. Am. J. Physiol. Cell Physiol. 2012, 303:C781-C789.
38. Dikalov S.I., Ungvari Z. Role of mitochondrial oxidative stress in hypertension. Am. J. Physiol. Heart Circ. Physiol. 2013, 305:H1417-H1427.
39. Yoganathan T.N., Costello P., Chen X., et al. Integrin-linked kinase (ILK): a "hot" therapeutic target. Biochem. Pharmacol. 2000, 60:1115-1119.